Benefits
Muscle mass preservation during inactivity and aging
The most robust clinical evidence for HMB is in muscle wasting conditions — bed rest, hospitalization, and aging-related sarcopenia. Multiple RCTs show HMB (3 g/day) reduces muscle loss during immobilization and aging, with elderly populations showing the greatest benefit. Evidence in cancer cachexia is weaker and not conclusive. HMB is included in some ICU nutrition protocols.
Strength and lean mass in untrained individuals
In untrained or recreationally active individuals beginning resistance training, HMB significantly accelerates strength gains and lean mass increases compared to training alone. Effect sizes are larger than in trained athletes, suggesting HMB is most beneficial during the early adaptation phase or after periods of detraining.
Exercise-induced muscle damage reduction
HMB reduces exercise-induced muscle damage markers (creatine kinase, lactate dehydrogenase) and reduces delayed onset muscle soreness (DOMS) following unaccustomed exercise. This anti-catabolic effect supports faster recovery between training sessions, particularly beneficial when training frequency is high or volume is suddenly increased.
Anti-catabolic effect via ubiquitin-proteasome inhibition
HMB reduces muscle protein breakdown by inhibiting the ubiquitin-proteasome pathway — the major intracellular protein degradation system activated during stress, immobilization, and aging. This anti-catabolic mechanism is distinct from and complementary to leucine's mTOR-mediated pro-anabolic effects.
Mechanism of action
mTORC1 activation and protein synthesis stimulation
HMB activates mTORC1 signaling — the master regulator of muscle protein synthesis — through mechanisms partially independent of leucine's direct mTOR activation. HMB activates the PI3K/Akt pathway upstream of mTOR, stimulating ribosomal S6 kinase 1 (S6K1) and 4E-BP1 phosphorylation to initiate muscle protein synthesis.
Ubiquitin-proteasome pathway inhibition
HMB downregulates expression of ubiquitin ligases (MuRF1, MAFbx/atrogin-1) that tag muscle proteins for proteasomal degradation. By reducing this catabolic pathway, HMB preserves existing muscle protein during catabolic conditions — explaining the anti-wasting effects in immobilization, aging, and disease states that are more consistent than the anabolic effects in healthy trained athletes.
Cholesterol synthesis via the mevalonate pathway (minor route)
A small fraction of HMB (roughly 5 percent) is converted to HMG-CoA and can enter the mevalonate pathway toward cholesterol synthesis. This has been proposed as a route by which HMB might supply cholesterol for repair of muscle-cell membranes after exercise, but it is a minor metabolic pathway and the membrane-repair role has not been shown to drive HMB's benefits in humans.
Clinical trials
Randomized, double-blind, placebo-controlled trial of HMB-calcium (3 g/day) vs placebo in 24 healthy older adults during 10-day bed rest plus 8-week recovery. Outcomes: lean body mass (DXA), strength, function. (Deutz et al. 2013, Clin Nutr)
24 healthy older adults. 10-day bed rest + 8-week recovery.
HMB attenuated lean body mass loss during bed rest: the placebo group lost 2.05 kg of lean mass while the HMB group essentially preserved it (about -0.17 kg with one outlier excluded), a significant between-group difference (p=0.02). Promising signal for muscle preservation in catabolic conditions. Note: small sample (n=24); applicable to bed rest/immobilization populations more than healthy training contexts.
Meta-analysis of 10 randomized controlled trials (324 participants for creatine kinase, 229 for lactate dehydrogenase) assessing HMB supplementation effects on markers of exercise-induced muscle damage. (Rahimi et al. 2018, J Am Coll Nutr)
Pooled across multiple RCTs.
HMB significantly reduced post-exercise creatine kinase (weighted mean difference about -60.7 U/L) and lactate dehydrogenase (about -15.4 U/L), with the effect on damage markers clearest in studies lasting six weeks or longer. This meta-analysis pooled blood damage markers, not soreness or strength directly. Critical context: HMB has been heavily marketed in bodybuilding for muscle building in resistance-trained adults — the evidence for this population is much weaker than for catabolic conditions (sarcopenia, bed rest, illness). The ISSN position stand notes HMB's anabolic effect is modest and, for trained individuals, less effective than creatine plus adequate protein.